Across TCGA pan-cancer cohorts, IL3RA Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated IL3RA data layer compared with 25 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher IL3RA Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IL3RA expression acts as an unfavorable survival marker.

LUAD, READ, and COAD are the cancer types where IL3RA Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.301	0.683	.007	10	view →
READ	OS	Median	All	0.281	0.830	.006	3	view →
COAD	OS	Median	All	0.671	0.873	.049	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: IL3RA tumor-vs-normal RNA expression · all IL3RA data types